908 Devices Inc , a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.
info908 Devices is a micro cap stock with a total market cap of 239.27M.
infoThey trade on the NASDAQ and had their IPO 2 years and 8 months ago.
info908 Devices currently employs 227 people.
infoAs of Wednesday, Aug 23 2023, 908 Devices’s share price is $7.4.
News Relating to 908 Devices
24/7 Wall Street
Cathie Wood’s ARK Funds Are Loading Up on These 5 Red-Hot Stocks Trading Under $10
Saturday Aug 12 2023 at 06:15
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Seeking Alpha
908 Devices, Inc. (MASS) Q2 2023 Earnings Call Transcript
Tuesday Aug 08 2023 at 22:50
908 Devices, Inc. (NASDAQ:MASS ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Kelly Gura – IR Kevin Knopp – Co-Founder, CEO, President & Director Joseph Griffith – CFO & Treasurer Conference Call Participants Daniel Arias – Stifel Steven Mah – TD Cowen Matthew Larew – William Blair Operator Hello, and welcome to today’s 908 Devices Second Quarter 2023 Financial Results Conference Call. My name is Jordan, and I’ll be coordinating your call today.
Zacks Investment Research
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
Tuesday Aug 08 2023 at 10:40
908 Devices Inc. (MASS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.26 per share a year ago.
Zacks Investment Research
908 Devices Inc. (MASS) Soars 8.5%: Is Further Upside Left in the Stock?
Thursday Jul 13 2023 at 07:21
908 Devices Inc. (MASS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
24/7 Wall Street
5 Sizzling ‘Strong Buy’ Stocks Under $10, and ARK’s Cathie Wood Loves 3 of Them
Saturday Jul 08 2023 at 06:05
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
24/7 Wall Street
5 ‘Strong Buy’ Stocks to Buy Under $10, and Cathie Wood’s Ark Owns 2 of Them
Saturday Jun 03 2023 at 06:10
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Zacks Investment Research
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
Tuesday May 09 2023 at 09:56
908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago.
Zacks Investment Research
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
Tuesday Mar 07 2023 at 09:47
908 Devices Inc. (MASS) delivered earnings and revenue surprises of -40.91% and 1.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Business Wire
908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
Tuesday Feb 14 2023 at 07:00
BOSTON–(BUSINESS WIRE)–908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the fourth quarter and full year 2022 before market open on Tuesday, March 7, 2023. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
Seeking Alpha
908 Devices: The Bull Vs. Bear Tug Of War
Tuesday Feb 14 2023 at 04:39
908 Devices is a highly rated stock by Wall Street analysts. Seeking Alpha quant ratings state the stock “is at a high risk of performing badly.”
Seeking Alpha
908 Devices Inc. (MASS) Q3 2022 Earnings Call Transcript
Monday Nov 14 2022 at 15:23
908 Devices Inc. (NASDAQ:MASS ) Q3 2022 Results Conference Call November 14, 2022 8:30 AM ET Company Participants Kelly Gura – IR Kevin Knopp – CEO and Co-Founder Joe Griffith – CFO Conference Call Participants Max Masucci – Cowen Daniel Arias – Stifel Puneet Souda – Leerink Madeline Mollman – William Blair Operator Good day and thank you for standing by. Welcome to the 908 Devices Third Quarter 2022 Financial Results Conference Call.
The Motley Fool
Why 908 Devices Stock Is Sinking Today
Monday Nov 14 2022 at 11:44
Investors didn’t like the medical device maker’s update.
Business Wire
908 Devices to Participate in Upcoming Investor Conferences
Wednesday Nov 02 2022 at 07:00
BOSTON–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following investor conferences in New York, NY.
Seeking Alpha
908 Devices Inc. (MASS) CEO Kevin Knopp on Q2 2022 Results – Earnings Call Transcript
Tuesday Aug 09 2022 at 14:17
908 Devices Inc. (NASDAQ:MASS ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Kelly Gura – Investor Relations Kevin Knopp – Chief Executive Officer & Co-Founder Joe Griffith – Chief Financial Officer Conference Call Participants Dan Arias – Stifel Max Masucci – Cowen Operator Hello, thank you for standing by. And welcome to the 908 Devices’ Second Quarter 2022 Financial Results Conference Call.
Business Wire
908 Devices to Report Second Quarter 2022 Financial Results on August 9, 2022
Tuesday Jul 19 2022 at 07:00
BOSTON–(BUSINESS WIRE)–908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2022 before market open on Tuesday, August 9, 2022. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company
Seeking Alpha
908 Devices, Inc. (MASS) CEO Kevin Knopp on Q1 2022 Results – Earnings Call Transcript
Tuesday May 10 2022 at 15:24
908 Devices, Inc. (NASDAQ:MASS ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Kelly Gura – Investor Relations Kevin Knopp – Chief Executive Officer & Co-Founder Joe Griffith – Chief Financial Officer Conference Call Participants Puneet Souda – SVB Securities Dan Arias – Stifel Brian Weinstein – William Blair Operator Good morning and thank you for standing by. Welcome to the 908 Devices’ First Quarter 2022 Financial Results Conference Call.
Zacks Investment Research
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
Tuesday May 10 2022 at 09:47
908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 8.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Business Wire
908 Devices to Report First Quarter Financial Results on May 10, 2022
Tuesday Apr 12 2022 at 07:00
BOSTON–(BUSINESS WIRE)–908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the first quarter 2022 before market open on Tuesday, May 10, 2022. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company we
The Motley Fool
Why 908 Devices Stock Rocketed 15% Higher Today
Tuesday Mar 08 2022 at 17:58
The niche healthcare company delivers a pair of convincing beats in its fourth quarter results.
Seeking Alpha
908 Devices Inc.’s (MASS) CEO Kevin Knopp on Q4 2021 Results – Earnings Call Transcript
Monday Mar 07 2022 at 23:00
908 Devices Inc.’s (MASS) CEO Kevin Knopp on Q4 2021 Results – Earnings Call Transcript
Zacks Investment Research
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
Monday Mar 07 2022 at 18:46
908 Devices Inc. (MASS) delivered earnings and revenue surprises of 33.33% and 4.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
24/7 Wall Street
Earnings Previews: Dick’s, Lithium Americas, 908 Devices, Petco
Friday Mar 04 2022 at 12:04
The number of companies posting quarterly results drops below 500 next week, as the current earnings-reporting season winds down.
Business Wire
908 Devices to Participate in Upcoming Investor Conferences
Thursday Nov 11 2021 at 07:00
BOSTON–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following virtual investor conferences. Stifel 2021 Virtual Healthcare Conference Fireside Chat on Wednesday, November 17th at 1:40 p.m. Pacific Time / 4:40 p.m. Eastern Time Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum Fireside Chat on Thursday, No
Seeking Alpha
908 Devices Inc. (MASS) CEO Kevin Knopp on Q3 2021 Results – Earnings Call Transcript
Saturday Nov 06 2021 at 15:44
908 Devices Inc. (MASS) CEO Kevin Knopp on Q3 2021 Results – Earnings Call Transcript
The Motley Fool
3 Sinking Stocks Cathie Wood Keeps Buying Anyway
Sunday Oct 03 2021 at 06:14
ARK Invest’s founder and CEO isn’t shy about averaging down on her favorite growth stocks.
GuruFocus
Cathie Wood Makes Adjustments to Portfolio in August
Monday Sep 13 2021 at 12:47
Catherine Wood (Trades, Portfolio) disclosed last week her firm, ARK Investment Management, made a number of changes to its portfolio in August.
Seeking Alpha
908 Devices Inc. (MASS) CEO Kevin Knopp on Q2 2021 Results – Earnings Call Transcript
Saturday Aug 07 2021 at 13:25
908 Devices Inc. (MASS) CEO Kevin Knopp on Q2 2021 Results – Earnings Call Transcript
Benzinga
908 Devices Shares Gain On Handheld, Desktop Devices Led Q2 Revenue Beat, FY21 Guidance Above Consensus
Wednesday Aug 04 2021 at 14:34
908 Devices Inc (NASDAQ: MASS) reported a second-quarter FY21 revenue decline of 26% year-on-year to $8.3 million, beating the analyst consensus of $7.2 million. The revenue grew 49% Q/Q.
Business Wire
908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights
Tuesday Jun 22 2021 at 07:01
BOSTON–(BUSINESS WIRE)–908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced two data analysis partnerships to integrate with the REBEL™, the first at-line fresh and spent cell media analyzer for bioprocess labs. With the integration of leading data exploratory tool Sartorius’ SIMCA® and Securecell’s Lucullus Process Information Management System (PIMS), users can seamlessly turn REBEL data into dee
Seeking Alpha
908 Devices: Buying The Dip
Sunday May 16 2021 at 11:52
908 Devices continues to have real potential, but still has to deliver as the business is quite lumpy. I like the potential of the business, driven by customer testimonials and the addressable market, yet some real execution would be welcomed.
908 Devices Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
908 Devices’s Altman Z-score is 3.41 which is in the safe zone. This indicates the company is financially stable and less likely to experience financial distress or bankruptcy.
Derived from SEC.GOV filing dataopen_in_new
908 Devices Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, 2 insiders have sold $752.23K of common stock in 908 Devices on the stock market with no insider buying.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
908 Devices’s Income Quality of 0.59 is lower than its Industry Group of 0.81 (-27.2% lower)
908 Devices’s Income Quality of 0.59 is lower than its Major Industry Group of 0.71 (-16.9% lower)
908 Devices’s Income Quality of 0.59 is lower than its Sector of 0.75 (-21.3% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
908 Devices’s Current Ratio of 8.97 is greater than its Industry Group of 3.01 (198.0% greater)
908 Devices’s Current Ratio of 8.97 is greater than its Major Industry Group of 3.13 (186.6% greater)
908 Devices’s Current Ratio of 8.97 is greater than its Sector of 2.6 (245.0% greater)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-6.87 & 10.69)
Cannot compare a negative PE Ratio (-6.87 & -0.58)
Cannot compare a negative PE Ratio (-6.87 & -0.4)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
908 Devices’s PB Ratio of 1.37 is lower than its Industry Group of 2.33 (-41.2% lower)
908 Devices’s PB Ratio of 1.37 is lower than its Major Industry Group of 1.93 (-29.0% lower)
908 Devices’s PB Ratio of 1.37 is lower than its Sector of 1.62 (-15.4% lower)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
908 Devices’s ROE of -0.2 is lower than its Industry Group of 0.02 (-1100.0% lower)
908 Devices’s ROE of -0.2 is lower than its Major Industry Group of -0.09 (-122.2% lower)
908 Devices’s ROE of -0.2 is lower than its Sector of -0.03 (-566.7% lower)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
908 Devices’s ROCE of -0.22 is lower than its Industry Group of 0.01 (-2300.0% lower)
908 Devices’s ROCE of -0.22 is lower than its Major Industry Group of -0.14 (-57.1% lower)
908 Devices’s ROCE of -0.22 is lower than its Sector of -0.04 (-450.0% lower)
Derived from SEC.GOV filing dataopen_in_new